These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7930229)

  • 21. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors.
    Katz SD; Schwarz M; Yuen J; LeJemtel TH
    Circulation; 1993 Jul; 88(1):55-61. PubMed ID: 8391403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does lipoprotein(a) impair endothelial function?
    Schlaich MP; John S; Langenfeld MR; Lackner KJ; Schmitz G; Schmieder RE
    J Am Coll Cardiol; 1998 Feb; 31(2):359-65. PubMed ID: 9462580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients.
    Brush JE; Faxon DP; Salmon S; Jacobs AK; Ryan TJ
    J Am Coll Cardiol; 1992 Mar; 19(4):809-15. PubMed ID: 1545076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial function in chronic congestive heart failure.
    Drexler H; Hayoz D; Münzel T; Hornig B; Just H; Brunner HR; Zelis R
    Am J Cardiol; 1992 Jun; 69(19):1596-601. PubMed ID: 1598876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
    Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
    Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of effect of vitamin E on L-arginine-responsive endothelial dysfunction in patients with mild hypercholesterolaemia and coronary artery disease.
    Chowienczyk PJ; Kneale BJ; Brett SE; Paganga G; Jenkins BS; Ritter JM
    Clin Sci (Lond); 1998 Feb; 94(2):129-34. PubMed ID: 9536920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between flow-mediated brachial artery vasodilation and coronary vasomotor responses to bradykinin: comparison with those to acetylcholine.
    Matsuo S; Matsumoto T; Takashima H; Ohira N; Yamane T; Yasuda Y; Tarutani Y; Horie M
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):164-70. PubMed ID: 15243296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure.
    Schwarz M; Katz SD; Demopoulos L; Hirsch H; Yuen JL; Jondeau G; LeJemtel TH
    Circulation; 1994 Apr; 89(4):1609-14. PubMed ID: 8149528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aging-associated endothelial dysfunction in humans is reversed by L-arginine.
    Chauhan A; More RS; Mullins PA; Taylor G; Petch C; Schofield PM
    J Am Coll Cardiol; 1996 Dec; 28(7):1796-804. PubMed ID: 8962569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
    Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A
    Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients.
    Casino PR; Kilcoyne CM; Quyyumi AA; Hoeg JM; Panza JA
    Circulation; 1993 Dec; 88(6):2541-7. PubMed ID: 8252665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vasodilator effects of bradykinin on the resistive circulation of the forearm of coronary patients].
    Benacerraf S; Carville C; Sediame S; Belhassen L; Adnot S; Dubois-Randé JL
    Arch Mal Coeur Vaiss; 2000 Sep; 93(9):1103-8. PubMed ID: 11055001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.
    Zanzinger J; Zheng X; Bassenge E
    Cardiovasc Res; 1994 Feb; 28(2):209-14. PubMed ID: 8143302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective loss of microvascular endothelial function in human hypercholesterolemia.
    Gilligan DM; Guetta V; Panza JA; García CE; Quyyumi AA; Cannon RO
    Circulation; 1994 Jul; 90(1):35-41. PubMed ID: 8026018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries.
    Sudhir K; MacGregor JS; DeMarco T; De Groot CJ; Taylor RN; Chou TM; Yock PG; Chatterjee K
    Circulation; 1994 Dec; 90(6):3018-23. PubMed ID: 7994850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease.
    Settergren M; Böhm F; Malmström RE; Channon KM; Pernow J
    Atherosclerosis; 2009 May; 204(1):73-8. PubMed ID: 18849028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure.
    Nakamura M; Funakoshi T; Arakawa N; Yoshida H; Makita S; Hiramori K
    J Am Coll Cardiol; 1994 Nov; 24(5):1321-7. PubMed ID: 7930256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of potassium on vasodilation to acetylcholine in essential hypertension.
    Taddei S; Mattei P; Virdis A; Sudano I; Ghiadoni L; Salvetti A
    Hypertension; 1994 Apr; 23(4):485-90. PubMed ID: 8144217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term treatment with eicosapentaenoic acid improves exercise-induced vasodilation in patients with coronary artery disease.
    Tagawa T; Hirooka Y; Shimokawa H; Hironaga K; Sakai K; Oyama J; Takeshita A
    Hypertens Res; 2002 Nov; 25(6):823-9. PubMed ID: 12484504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease.
    Tagawa H; Shimokawa H; Tagawa T; Kuroiwa-Matsumoto M; Hirooka Y; Takeshita A
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):633-40. PubMed ID: 10218735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.